| # | Drug | Count |
|---|---|---|
| 0 | PORACTANT ALFA | 18 |
| 1 | LAMIVUDINE | 4 |
| 2 | LAMIVUDINE ORAL | 4 |
| 3 | ATROPINE | 3 |
| 4 | ATROPINE SULFATE | 3 |
| 5 | DOBUTAMINE | 3 |
| 6 | DOPAMINE | 3 |
| 7 | DOPAMINE HYDROCHLORIDE | 3 |
| 8 | ARIPIPRAZOLE | 2 |
| 9 | CAFFEINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORACTANT ALFA | 18 | 0.0244 |
| 1 | DOPAMINE HYDROCHLORIDE | 3 | 0.0008 |
| 2 | DOBUTAMINE | 3 | 0.0008 |
| 3 | NITRIC OXIDE | 2 | 0.0004 |
| 4 | CAFFEINE CITRATE | 1 | 0.0004 |
| 5 | ALOGLIPTIN | 1 | 0.0003 |
| 6 | PHYTONADIONE | 2 | 0.0002 |
| 7 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 8 | LAMIVUDINE | 4 | 0.0002 |
| 9 | AMPICILLIN INJECTION | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 18 | 0.0155 |
| 1 | Vitamin K [EPC] | 2 | 0.0002 |
| 2 | Anticholinergic [EPC] | 3 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 3 | 0.0001 |
| 5 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 6 | Catecholamine [EPC] | 3 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 8 | Methylxanthine [EPC] | 2 | 0.0000 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |